Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ayoub

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Kidney360|April 14, 2022
Validating a Computable Phenotype for Nephrotic Syndrome in Children and Adults Using PCORnet DataAndrea L Oliverio, Dorota Marchel, Jonathan P Troost, et al.
Kidney International Reports|February 22, 2021
Establishing a Case for Anti-complement Therapy in Membranous NephropathyIsabelle Ayoub, John P Shapiro, Huijuan Song, et al.
Kidney International Reports|September 18, 2024
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous NephropathyBrad H Rovin, Pierre M Ronco, Jack F M Wetzels, et al.
Kidney International|July 5, 2022
Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritisSamir V Parikh, Ana Malvar, Huijuan Song, et al.
Kidney International Reports|April 18, 2023
Pregnancy History and Kidney Disease Progression Among Women Enrolled in Cure GlomerulonephropathyMonica L Reynolds, Andrea L Oliverio, Jarcy Zee, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 7, 2023
Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy NetworkDhruti P Chen, Margaret E Helmuth, Abigail R Smith, et al.
JAMA Network Open|June 26, 2024
Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 DiabetesDaniel Edmonston, Elizabeth Lydon, Hillary Mulder, et al.
Kidney International Reports|June 20, 2024
Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated VasculitisReza Zonozi, Faten Aqeel, Dustin Le, et al.
Kidney Medicine|April 11, 2025
Clinical Decision-Making About Immunosuppressive Treatment in Focal Segmental GlomerulosclerosisBrooke Blazius, Jonathan P Troost, Jeffrey B Kopp, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 10, 2023
Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 GenotypesMahmoud Kallash, Yujie Wang, Abigail Smith, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Kidney360|April 14, 2022
Validating a Computable Phenotype for Nephrotic Syndrome in Children and Adults Using PCORnet DataAndrea L Oliverio, Dorota Marchel, Jonathan P Troost, et al.
Kidney International Reports|February 22, 2021
Establishing a Case for Anti-complement Therapy in Membranous NephropathyIsabelle Ayoub, John P Shapiro, Huijuan Song, et al.
Kidney International Reports|September 18, 2024
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous NephropathyBrad H Rovin, Pierre M Ronco, Jack F M Wetzels, et al.
Kidney International|July 5, 2022
Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritisSamir V Parikh, Ana Malvar, Huijuan Song, et al.
Kidney International Reports|April 18, 2023
Pregnancy History and Kidney Disease Progression Among Women Enrolled in Cure GlomerulonephropathyMonica L Reynolds, Andrea L Oliverio, Jarcy Zee, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 7, 2023
Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy NetworkDhruti P Chen, Margaret E Helmuth, Abigail R Smith, et al.
JAMA Network Open|June 26, 2024
Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 DiabetesDaniel Edmonston, Elizabeth Lydon, Hillary Mulder, et al.
Kidney International Reports|June 20, 2024
Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated VasculitisReza Zonozi, Faten Aqeel, Dustin Le, et al.
Kidney Medicine|April 11, 2025
Clinical Decision-Making About Immunosuppressive Treatment in Focal Segmental GlomerulosclerosisBrooke Blazius, Jonathan P Troost, Jeffrey B Kopp, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 10, 2023
Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 GenotypesMahmoud Kallash, Yujie Wang, Abigail Smith, et al.
Pageof 4